Detection of hypoxia with 18F-fluoromisonidazole ( 18F-FMISO) PET/CT in suspected or proven pancreatic cancer

T. Segard, P.D. Robins, Ian Yusoff, H. Ee, L. Morandeau, E.M. Campbell, Roslyn Francis

Research output: Contribution to journal › Article › peer-review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{d9e694b4d1744ba8b04bad6d0d50db42,

title = "Detection of hypoxia with 18F-fluoromisonidazole ( 18F-FMISO) PET/CT in suspected or proven pancreatic cancer",

author = "T. Segard and P.D. Robins and Ian Yusoff and H. Ee and L. Morandeau and E.M. Campbell and Roslyn Francis",

year = "2013",

doi = "10.1097/RLU.0b013e3182708777",

language = "English",

volume = "38",

pages = "1--6",

journal = "Clinical Nuclear Medicine",

issn = "0363-9762",

publisher = "Lippincott Williams & Wilkins",

number = "7",

}

TY - JOUR

T1 - Detection of hypoxia with 18F-fluoromisonidazole ( 18F-FMISO) PET/CT in suspected or proven pancreatic cancer

AU - Segard, T.

AU - Robins, P.D.

AU - Yusoff, Ian

AU - Ee, H.

AU - Morandeau, L.

AU - Campbell, E.M.

AU - Francis, Roslyn

PY - 2013

Y1 - 2013

U2 - 10.1097/RLU.0b013e3182708777

DO - 10.1097/RLU.0b013e3182708777

M3 - Article

C2 - 23242037

VL - 38

SP - 1

EP - 6

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

SN - 0363-9762

IS - 7

ER -